NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
Key Facts
Status: Forecasted
Posted date: May 28, 2026
Archive date: June 4, 2029
Close date: April 5, 2029
Opportunity ID: 359758
Opportunity number: PA-27-101
Opportunity category: Discretionary
Agency name: National Institutes of Health
Agency code: HHS-NIH11
Award floor: $0
Award ceiling: $0
Cost sharing required: Yes
Funding Instrument Types
- Grant
Category of Funding Activity
- Health
Eligible Applicants
- Small businesses
Tools
Categories (use these for quoted searches)
- agency_code:hhs_nih11
- category_of_funding_activity:health
- cost_sharing_or_matching_requirement:true
- eligible_applicants:small_businesses
- funding_instrument_type:grant
- opportunity_category:discretionary
- status:forecasted
Description
The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).